Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.

Locher CP, Witt SA, Herndier BG, Tenner-Racz K, Racz P, Levy JA.

Immunol Rev. 2001 Oct;183:127-40. Review.

PMID:
11782253
2.

Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans.

Locher CP, Barnett SW, Herndier BG, Blackbourn DJ, Reyes-Terán G, Murthy KK, Brasky KM, Hubbard GB, Reinhart TA, Haase AT, Levy JA.

Arch Pathol Lab Med. 1998 Jun;122(6):523-33.

PMID:
9625420
3.
4.

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.

Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA.

Vaccine. 2004 Jun 2;22(17-18):2261-72.

PMID:
15149785
5.

An AIDS-like condition induced in baboons by HIV-2.

Barnett SW, Murthy KK, Herndier BG, Levy JA.

Science. 1994 Oct 28;266(5185):642-6.

PMID:
7939718
6.

Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.

Locher CP, Blackbourn DJ, Barnett SW, Murthy KK, Cobb EK, Rouse S, Greco G, Reyes-Terán G, Brasky KM, Carey KD, Levy JA.

J Infect Dis. 1997 Oct;176(4):948-59.

PMID:
9333153
7.

Immune responses in baboons vaccinated with HIV-2 genetic expression libraries.

Locher CP, Sykes KF, Blackbourn DJ, Johnston SA.

J Med Primatol. 2002 Dec;31(6):323-9.

PMID:
12519210
8.

Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2.

Barnett SW, Legg HS, Sun Y, Klinger J, Blackbourn DJ, Locher CP, Levy JA.

Virology. 1996 Aug 1;222(1):257-61.

9.

Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons.

Burgers WA, Chege GK, Müller TL, van Harmelen JH, Khoury G, Shephard EG, Gray CM, Williamson C, Williamson AL.

J Gen Virol. 2009 Feb;90(Pt 2):468-80. doi: 10.1099/vir.0.004614-0.

PMID:
19141458
10.

The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.

Staprans SI, Feinberg MB.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S5-32. Review.

PMID:
15285703
11.

Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.

Locher CP, Witt SA, Herndier BG, Abbey NW, Tenner-Racz K, Racz P, Kiviat NB, Murthy KK, Brasky K, Leland M, Levy JA.

J Virol. 2003 Jan;77(1):77-83.

12.

Use of Old World monkeys for acquired immunodeficiency syndrome research.

Nicol I, Messinger D, Dubouch P, Bernard J, Desportes I, Jouffre R, Snart R, Nara P, Gallo RC, Zagury D.

J Med Primatol. 1989;18(3-4):227-36.

PMID:
2760915
13.

[HIV/AIDS vaccines: heading for new vaccine approaches?].

Girard MP.

Bull Soc Pathol Exot. 2008 Jun;101(3):220-6. French.

PMID:
18681215
14.

Particle-based vaccines for HIV-1 infection.

Young KR, Ross TM.

Curr Drug Targets Infect Disord. 2003 Jun;3(2):151-69. Review.

PMID:
12769792
15.

Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology.

Karpas A.

Biol Rev Camb Philos Soc. 2004 Nov;79(4):911-33. Review.

PMID:
15682876
16.

Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.

Leligdowicz A, Rowland-Jones S.

Expert Rev Vaccines. 2008 Apr;7(3):319-31. doi: 10.1586/14760584.7.3.319. Review.

PMID:
18393602
17.

HIV-1 and AIDS: what are protective immune responses?

Beattie T, Rowland-Jones S, Kaul R.

J HIV Ther. 2002 May;7(2):35-9. Review.

PMID:
12553686
18.

AIDS vaccine development: the long and winding road.

Garber DA, Feinberg MB.

AIDS Rev. 2003 Jul-Sep;5(3):131-9. Review.

PMID:
14598562
19.

Persistent infection of baboons and rhesus monkeys with different strains of HIV-2.

Castro BA, Nepomuceno M, Lerche NW, Eichberg JW, Levy JA.

Virology. 1991 Sep;184(1):219-26.

PMID:
1678564
20.

Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al.

Science. 1994 Sep 9;265(5178):1587-90.

PMID:
7915856

Supplemental Content

Support Center